On the Cyber Frontier of IoT Security
Client Alert | 1 min read | 04.11.18
In the Interagency Report on Status of International Cybersecurity Standardization for the Internet of Things (IoT), the National Institute of Standards and Technology (NIST) performed an extensive survey of current cybersecurity standards applicable or potentially applicable to IoT devices. Among the many key findings and discussions, some of the more notable are: (1) NIST elected not to define IoT due to the many varying definitions already in the field (see Annex A); (2) NIST used several functional IoT applications (connected vehicles, consumer devices, health/medical devices, smart buildings and smart manufacturing) to assess current cyber standards and gaps; (3) NIST recognized that no one-size-fits-all standards exist, as specific sectors will have differing risk scenarios and security objectives, thus requiring cyber standards to be tailored; and (4) IoT security should be built around eleven core areas of cybersecurity standardization. Also, NIST is looking for your comments on draft NISTIR 8200 by April 18. To learn more, join us at the IoT National Institute on May 9-10 in Washington, D.C.
Contacts
Insights
Client Alert | 4 min read | 09.15.26
GAO Indicates Reasonable Conflict of Interest Investigation Must Include Inquiry of Involved Firm
The U.S. Government Accountability Office’s (GAO) recent decision in Viderity Inc.—Costs, B-424422.5, Sept. 1, 2026, offers useful insight into what constitutes a legally sufficient conflict of interest investigation. The decision arose in an unusual procedural posture: Viderity initially protested, alleging that an agency evaluator had a personal conflict of interest. After the agency took corrective action, Viderity filed a cost entitlement claim requesting that GAO direct the agency to reimburse Viderity’s protest costs. In evaluating that claim, GAO assessed whether Viderity’s underlying protest ground was “clearly meritorious.”
Client Alert | 3 min read | 09.15.26
Client Alert | 7 min read | 09.14.26
AI in Life Sciences: Ten Legal Considerations and Risks of AI Use in Drug Discovery and Development
Client Alert | 6 min read | 09.14.26
Mental Health Parity Bulletin Restates Best Practices for Evaluating Compliance

